Streetbeat News

Stock Prices

TSLA

Tesla, Inc. (NASDAQ:TSLA) reduced the prices of its Model S, X, and Y vehicles in the U.S. by $2,000, marking a strategy shift that has previously been criticized. This move comes as Tesla faces negative volume growth, with first-quarter deliveries declining year-over-year for the first time since Q2 2020. The price cuts are seen as a response to declining auto gross margins and overall pressure on the EV industry. Tesla also ended its referral program in the U.S. and announced layoffs, including high-profile executives. The company is set to report its first-quarter results soon, with analysts expecting a decrease in earnings per share and revenue compared to the previous year.

Portfolio Pulse from Shanthi Rexaline

April 20, 2024 | 3:57 am

BTCUSD

Bitcoin whales have acquired over $1.2 billion worth of BTC during a recent market dip, with their actions potentially signaling a forthcoming rally. The accumulation of 19,760 BTC occurred as Bitcoin's price fell below $60,000, contributing to a recovery to around $65,000. This behavior indicates a shift in market sentiment and could precede a rise in Bitcoin's price.

Portfolio Pulse from Rounak Jain

April 20, 2024 | 3:01 am

BTCUSD

Bitcoin experienced a 1.5% increase following its fourth halving event, where mining rewards were reduced from 6.25 BTC to 3.125 BTC. This event, which aims to manage scarcity and control inflation, has historically led to bullish market trends. Despite predictions of short-term volatility, there's optimism for Bitcoin's long-term price, with billionaire investor Tim Draper forecasting a rise to $250,000. The global cryptocurrency market cap surged by 4.7%, with significant spikes in crypto liquidations and exchange inflows.

Portfolio Pulse from Navdeep Yadav

April 20, 2024 | 12:56 am

SMFL

Trading for SMFL was halted at 7:50:00 p.m. ET due to pending news. The halt is a temporary measure until the news affecting the company is released.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 11:50 pm

HEPA

Hepion Pharmaceuticals shares have resumed trading, indicating a return to market activity for the company.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 9:05 pm

AAPL

Sen. Elizabeth Warren criticized Apple Inc (NASDAQ:AAPL) for its smartphone market 'monopoly', particularly highlighting how the green text bubbles for non-iPhone users can ruin relationships and lead to social exclusion. Warren's comments support a Department of Justice antitrust case against Apple, focusing on the company's control over the smartphone market and its practices that lock users into its services. The DOJ's lawsuit includes claims of social stigmatization due to the blue vs. green text bubble issue, with Apple holding a 57% market share in North America as of January 2024.

Portfolio Pulse from Chris Katje

April 19, 2024 | 8:57 pm

HEPA

Trading for HEPA was halted and then resumed at 4:55:00 PM ET, with updates on quotation resumption, news, and resumption times provided.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 8:55 pm

COSM

Cosmos Health received a Nasdaq notice for the late filing of its Form 10-K. On April 17, the company was notified of non-compliance with Nasdaq Listing Rule 5250(c)(1). Cosmos Health intends to resolve this deficiency and regain compliance with Nasdaq listing rules, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 8:48 pm

NOW

Whales have shown a bearish stance on ServiceNow (NYSE:NOW), with options trading indicating a mix of bullish and bearish expectations. Notable trades include a range of puts and calls, targeting a price range from $300 to $1040. ServiceNow's current trading volume is 1,536,830, with a recent price drop of -2.39%, and an earnings announcement expected in 5 days.

Portfolio Pulse from Benzinga Insights

April 19, 2024 | 8:45 pm

AZN

AstraZeneca (NASDAQ:AZN) has seen significant bearish options activity, with 83% of traders showing bearish tendencies and a focus on a price band between $66.0 and $77.5. The largest options trades indicate a bearish sentiment despite a small portion of bullish activity. AstraZeneca, a major pharmaceutical company, has its stock slightly up by 0.28% at $68.55, with an upcoming earnings report in 6 days.

Portfolio Pulse from Benzinga Insights

April 19, 2024 | 8:45 pm